Koers Kamada Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
IL0010941198
Farmaceutische producten
Omzet 2024 * | 573 mln. 153 mln. 143 mln. | Omzet 2025 * | 706 mln. 189 mln. 176 mln. | Marktkapitalisatie | 1,14 mld. 305 mln. 285 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 46 mln. 12,28 mln. 11,47 mln. | Nettowinst (verlies) 2025 * | 84 mln. 22,43 mln. 20,95 mln. | EV/omzet 2024 * | 1,99 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,62 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 54,25% |
Recentste transcriptie over Kamada Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Amir London
CEO | Chief Executive Officer | 55 | 09-12-13 |
David Tsur
FOU | Founder | 73 | 13-12-90 |
Chaime Orlev
DFI | Director of Finance/CFO | 53 | 31-12-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 24-12-19 |
Leon Recanati
BRD | Director/Board Member | 76 | 01-05-05 |
David Tsur
FOU | Founder | 73 | 13-12-90 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,93% | 86,16 mld. | |
+2,76% | 40,17 mld. | |
-16,48% | 31,47 mld. | |
+54,25% | 25,24 mld. | |
-13,58% | 15,82 mld. | |
-9,12% | 11,96 mld. | |
-42,56% | 11,61 mld. | |
+6,44% | 8,84 mld. | |
-1,99% | 7,93 mld. |